Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

Clinical trial NCT05070845 · RECRUITING

Trial details

NCT number: NCT05070845
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Immune Thrombocytopenia

Start date: 2022-02-02
Primary completion: 2028-08-02
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.